Valeant Pharmaceuticals International (VRX) 31.09
Post# of 273332
Posted On: 03/26/2016 1:04:22 AM
Valeant Pharmaceuticals International (VRX) 31.09 $VRX
Krispy Is Kremed; RIP Andy Grove; Biotechs in No-Man's Land: Jim Cramer's Best Blogs
at The Street - Fri Mar 25, 8:00PM CDT
Cramer dissects Krispy Kreme, honors a tech pioneer and laments the state of biotech stocks.
BIIB: 254.69 (-0.55), VRX: 31.09 (-2.34), WMT: 68.00 (+0.54), INTC: 31.88 (-0.12), SHLD: 15.00 (+0.04), AGN: 279.32 (-1.99), SBUX: 58.36 (-0.47), JACK: 63.12 (+0.02), JNJ: 108.31 (-0.19), DNKN: 45.32 (-0.21), IBM: 147.95 (+2.55), CMG: 471.37 (-3.09), ABBV: 56.12 (-0.24), SNY: 38.87 (-0.53), KKD: 14.61 (+0.32), REGN: 370.80 (+5.42), HD: 130.46 (+0.24), PFE: 30.08 (-0.11), LLY: 71.12 (-0.05), GSK: 39.56 (+0.19), BMY: 62.52 (+0.18), PLKI: 51.07 (+0.98), DIN: 92.00 (-1.02), CELG: 100.54 (+0.62), QSR: 37.63 (-0.38), GILD: 91.32 (+1.24), MRK: 53.07 (-0.01), AZN: 28.00 (-0.01), MCD: 123.29 (-0.90), WEN: 10.42 (+0.06)
A Scam Called Valeant
David Stockman - Daily Reckoning - Fri Mar 25, 3:28PM CDT
This post A Scam Called Valeant appeared first on Daily Reckoning . David Stockman shows you how financial justice has finally caught up with one of the darlings of “bubble finance”... The post A Scam Called Valeant appeared first on Daily...
VRX: 31.09 (-2.34)
Jim Cramer -- Biotech Stocks' Window of Opportunity
at The Street - Fri Mar 25, 1:30PM CDT
Jim Cramer says that biotech stocks could have a window of opportunity to rally as Valeant rebounds and as politicians lay off the sector.
VRX: 31.09 (-2.34), IBB: 255.48 (+1.22)
Valeant Pharmaceuticals Down 60%, but It's Still Not a Good Buy
Motley Fool Staff - Motley Fool - Fri Mar 25, 7:19AM CDT
Recently, Valeant Pharmaceuticals shares dropped 60% in a week after it announced on March 15 it would miss its annual report deadline -- and this was after the stock tanked by almost 90% in the past eight months. But even though a few notorious...
VRX: 31.09 (-2.34)
CEO of investment firm burned by Valeant stake is retiring
AP - Thu Mar 24, 6:21PM CDT
NEW YORK (AP) — The CEO of the investment firm with the largest stake in troubled Valeant Pharmaceuticals is retiring after the firm suffered punishing losses from its bets on the drug company.
VRX: 31.09 (-2.34), VRX.TO: 41.21 (-2.95)
If It Wasn't For Pfizer, Allergan Investors Might Be Getting Pummeled
Todd Campbell, The Motley Fool - Motley Fool - Thu Mar 24, 8:21AM CDT
SOURCE: FLICKR USER STOCKMONKEYS.COM The unraveling of its buy-reprice-relaunch strategy has led to shares in Valeant Pharmaceuticals crumbling 80% in the past year, but Valeant Pharmaceuticals is far from the only publicly traded biopharma...
AGN: 279.32 (-1.99), VRX: 31.09 (-2.34), PFE: 30.08 (-0.11), HZNP: 16.02 (-0.30), TEVA: 54.29 (+0.24), DEPO: 13.31 (+0.17)
Valeant (VRX) Stock Climbs, Ackman Attempts to Reassure Investors
at The Street - Wed Mar 23, 12:16PM CDT
Valeant (VRX) stock is higher in afternoon trading on Wednesday as activist investor Bill Ackman explains to his own investors why he continues to believe in the company.
VRX: 31.09 (-2.34)
Trending Tickers: XOM, NKE, PBR, KKD, VRX
at The Street - Wed Mar 23, 12:04PM CDT
Oil prices continued to dictate market results on Wednesday as both the commodity and major indices declined.
PBR: 5.40 (+0.04), VRX: 31.09 (-2.34), NKE: 61.65 (-0.79), XOM: 83.98 (+0.23)
Valeant Pharmaceuticals International Set to Possibly Pullback After Yesterday's Rally of 6.08%
Comtex SmarTrend(R) - Wed Mar 23, 11:58AM CDT
Valeant Pharmaceuticals International (NYSE:VRX) traded in a range yesterday that spanned from a low of $32.42 to a high of $34.40. Yesterday, the shares gained 6.1%, which took the trading range above the 3-day high of $32.05 on volume of 25.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
VRX: 31.09 (-2.34)
Valeant Vs. Sears: Will Bill Ackman Win This Time?
at The Street - Wed Mar 23, 11:29AM CDT
Bill Ackman's persistence to stay aboard a plunging Valeant hints at a lesson gleaned from his Sears investment years ago.
VRX: 31.09 (-2.34), SHLD: 15.00 (+0.04)
Is It Time to Buy Valeant Again?
at The Street - Wed Mar 23, 10:32AM CDT
Embattled Valeant Pharmaceuticals has enacted major management and operational changes. Will they be enough to turn around the scandal-plagued drug company?
VRX: 31.09 (-2.34)
Why Valeant Pharmaceuticals' Stock Rose 10% on Tuesday
George Budwell, The Motley Fool - Motley Fool - Wed Mar 23, 8:10AM CDT
Source: Flickr via user stockmonkeys.com. What's happening : Shares of Valeant Pharmaceuticals finally saw a green day yesterday, gaining 10% on extraordinary volume for the stock. The company's shares have been getting blasted during the last...
VRX: 31.09 (-2.34), HZNP: 16.02 (-0.30)
Cramer: Nike's Stock Might Rebound After the Easter Weekend
at The Street - Wed Mar 23, 5:30AM CDT
The stock may go the way of all quickly judged stocks in this market.
MNK: 60.06 (-0.38), VRX: 31.09 (-2.34), VAL: 105.88 (+0.88), NKE: 61.65 (-0.79), SHW: 281.35 (-1.64)
3 Beaten-Up Healthcare Stocks: Are They Bargains?
Todd Campbell, The Motley Fool - Motley Fool - Tue Mar 22, 9:26PM CDT
SOURCE: FLICKR USER ELLIOTT BROWN. A sharp sell-off in healthcare stocks has left many investors licking their wounds, but other investors might be licking their chops. With many healthcare stocks trading at their lowest valuation in years, the...
JNJ: 108.31 (-0.19), VRX: 31.09 (-2.34), AKRX: 24.37 (-0.40), DEPO: 13.31 (+0.17)
Stocks Run in Place as Brussels Attack Paralyzes Wall Street
at The Street - Tue Mar 22, 3:09PM CDT
A quieter holiday trading week was disrupted by tragedy on Tuesday, with dual explosions at a Brussels airport and metro station reigniting global concerns about terrorism.
VRX: 31.09 (-2.34), DAL: 47.84 (-1.07), PFE: 30.08 (-0.11), DB: 17.54 (-0.46), LL: 13.15 (+0.61), PCLN: 1,301.19 (-4.92), CELG: 100.54 (+0.62), UAL: 57.84 (-1.90), LUV: 44.06 (-0.37), GILD: 91.32 (+1.24), EXPE: 107.69 (-1.30), AAL: 40.50 (-1.42), AAPL: 105.67 (-0.46), IHG: 39.52 (+0.12)
Valeant Bids CEO Farewell, Embraces Ackman, and Shareholders Love It
at The Street - Tue Mar 22, 1:40PM CDT
Updated to reflect management pressure on boardmember Howard Shiller to step down, as the troubled drugmaker adds Bill Ackman to its board and CEO Michael Pearson steps down.
VRX: 31.09 (-2.34)
Options Play: Sell Valeant Puts
at The Street - Tue Mar 22, 1:02PM CDT
VRX put premiums are high, so use them to your advantage.
VRX: 31.09 (-2.34)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Valeant Pharmaceuticals International, Inc. -- VRX
Business Wire - Tue Mar 22, 12:48PM CDT
Levi & Korsinsky, LLP announces that it has commenced an investigation of Valeant Pharmaceuticals International, Inc. ("Valeant Pharmaceuticals" or the "Company"
(NYSE:VRX) concerning possible violations of federal securities laws by certain officers and directors.
VRX: 31.09 (-2.34), VRX.TO: 41.21 (-2.95)
Trending Tickers: NKE, PBR, VRX, DKS
at The Street - Tue Mar 22, 12:10PM CDT
U.S. markets have been able to shake off investor fears following a terrorist attack in Belgium.
PBR: 5.40 (+0.04), VRX: 31.09 (-2.34), NKE: 61.65 (-0.79), DKS: 46.71 (+0.08), MFRM: 39.30 (+0.09)
Jim Cramer -- Bernie Sanders Dropout Could Rally Biotech Stocks
at The Street - Tue Mar 22, 11:57AM CDT
If Hillary Clinton can knock Bernie Sanders from the Democratic presidential race, it could spur a rally in the biotech sector, says Jim Cramer.
VRX: 31.09 (-2.34), AMGN: 149.24 (+0.48), IBB: 255.48 (+1.22)
Krispy Is Kremed; RIP Andy Grove; Biotechs in No-Man's Land: Jim Cramer's Best Blogs
at The Street - Fri Mar 25, 8:00PM CDT
Cramer dissects Krispy Kreme, honors a tech pioneer and laments the state of biotech stocks.
BIIB: 254.69 (-0.55), VRX: 31.09 (-2.34), WMT: 68.00 (+0.54), INTC: 31.88 (-0.12), SHLD: 15.00 (+0.04), AGN: 279.32 (-1.99), SBUX: 58.36 (-0.47), JACK: 63.12 (+0.02), JNJ: 108.31 (-0.19), DNKN: 45.32 (-0.21), IBM: 147.95 (+2.55), CMG: 471.37 (-3.09), ABBV: 56.12 (-0.24), SNY: 38.87 (-0.53), KKD: 14.61 (+0.32), REGN: 370.80 (+5.42), HD: 130.46 (+0.24), PFE: 30.08 (-0.11), LLY: 71.12 (-0.05), GSK: 39.56 (+0.19), BMY: 62.52 (+0.18), PLKI: 51.07 (+0.98), DIN: 92.00 (-1.02), CELG: 100.54 (+0.62), QSR: 37.63 (-0.38), GILD: 91.32 (+1.24), MRK: 53.07 (-0.01), AZN: 28.00 (-0.01), MCD: 123.29 (-0.90), WEN: 10.42 (+0.06)
A Scam Called Valeant
David Stockman - Daily Reckoning - Fri Mar 25, 3:28PM CDT
This post A Scam Called Valeant appeared first on Daily Reckoning . David Stockman shows you how financial justice has finally caught up with one of the darlings of “bubble finance”... The post A Scam Called Valeant appeared first on Daily...
VRX: 31.09 (-2.34)
Jim Cramer -- Biotech Stocks' Window of Opportunity
at The Street - Fri Mar 25, 1:30PM CDT
Jim Cramer says that biotech stocks could have a window of opportunity to rally as Valeant rebounds and as politicians lay off the sector.
VRX: 31.09 (-2.34), IBB: 255.48 (+1.22)
Valeant Pharmaceuticals Down 60%, but It's Still Not a Good Buy
Motley Fool Staff - Motley Fool - Fri Mar 25, 7:19AM CDT
Recently, Valeant Pharmaceuticals shares dropped 60% in a week after it announced on March 15 it would miss its annual report deadline -- and this was after the stock tanked by almost 90% in the past eight months. But even though a few notorious...
VRX: 31.09 (-2.34)
CEO of investment firm burned by Valeant stake is retiring
AP - Thu Mar 24, 6:21PM CDT
NEW YORK (AP) — The CEO of the investment firm with the largest stake in troubled Valeant Pharmaceuticals is retiring after the firm suffered punishing losses from its bets on the drug company.
VRX: 31.09 (-2.34), VRX.TO: 41.21 (-2.95)
If It Wasn't For Pfizer, Allergan Investors Might Be Getting Pummeled
Todd Campbell, The Motley Fool - Motley Fool - Thu Mar 24, 8:21AM CDT
SOURCE: FLICKR USER STOCKMONKEYS.COM The unraveling of its buy-reprice-relaunch strategy has led to shares in Valeant Pharmaceuticals crumbling 80% in the past year, but Valeant Pharmaceuticals is far from the only publicly traded biopharma...
AGN: 279.32 (-1.99), VRX: 31.09 (-2.34), PFE: 30.08 (-0.11), HZNP: 16.02 (-0.30), TEVA: 54.29 (+0.24), DEPO: 13.31 (+0.17)
Valeant (VRX) Stock Climbs, Ackman Attempts to Reassure Investors
at The Street - Wed Mar 23, 12:16PM CDT
Valeant (VRX) stock is higher in afternoon trading on Wednesday as activist investor Bill Ackman explains to his own investors why he continues to believe in the company.
VRX: 31.09 (-2.34)
Trending Tickers: XOM, NKE, PBR, KKD, VRX
at The Street - Wed Mar 23, 12:04PM CDT
Oil prices continued to dictate market results on Wednesday as both the commodity and major indices declined.
PBR: 5.40 (+0.04), VRX: 31.09 (-2.34), NKE: 61.65 (-0.79), XOM: 83.98 (+0.23)
Valeant Pharmaceuticals International Set to Possibly Pullback After Yesterday's Rally of 6.08%
Comtex SmarTrend(R) - Wed Mar 23, 11:58AM CDT
Valeant Pharmaceuticals International (NYSE:VRX) traded in a range yesterday that spanned from a low of $32.42 to a high of $34.40. Yesterday, the shares gained 6.1%, which took the trading range above the 3-day high of $32.05 on volume of 25.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
VRX: 31.09 (-2.34)
Valeant Vs. Sears: Will Bill Ackman Win This Time?
at The Street - Wed Mar 23, 11:29AM CDT
Bill Ackman's persistence to stay aboard a plunging Valeant hints at a lesson gleaned from his Sears investment years ago.
VRX: 31.09 (-2.34), SHLD: 15.00 (+0.04)
Is It Time to Buy Valeant Again?
at The Street - Wed Mar 23, 10:32AM CDT
Embattled Valeant Pharmaceuticals has enacted major management and operational changes. Will they be enough to turn around the scandal-plagued drug company?
VRX: 31.09 (-2.34)
Why Valeant Pharmaceuticals' Stock Rose 10% on Tuesday
George Budwell, The Motley Fool - Motley Fool - Wed Mar 23, 8:10AM CDT
Source: Flickr via user stockmonkeys.com. What's happening : Shares of Valeant Pharmaceuticals finally saw a green day yesterday, gaining 10% on extraordinary volume for the stock. The company's shares have been getting blasted during the last...
VRX: 31.09 (-2.34), HZNP: 16.02 (-0.30)
Cramer: Nike's Stock Might Rebound After the Easter Weekend
at The Street - Wed Mar 23, 5:30AM CDT
The stock may go the way of all quickly judged stocks in this market.
MNK: 60.06 (-0.38), VRX: 31.09 (-2.34), VAL: 105.88 (+0.88), NKE: 61.65 (-0.79), SHW: 281.35 (-1.64)
3 Beaten-Up Healthcare Stocks: Are They Bargains?
Todd Campbell, The Motley Fool - Motley Fool - Tue Mar 22, 9:26PM CDT
SOURCE: FLICKR USER ELLIOTT BROWN. A sharp sell-off in healthcare stocks has left many investors licking their wounds, but other investors might be licking their chops. With many healthcare stocks trading at their lowest valuation in years, the...
JNJ: 108.31 (-0.19), VRX: 31.09 (-2.34), AKRX: 24.37 (-0.40), DEPO: 13.31 (+0.17)
Stocks Run in Place as Brussels Attack Paralyzes Wall Street
at The Street - Tue Mar 22, 3:09PM CDT
A quieter holiday trading week was disrupted by tragedy on Tuesday, with dual explosions at a Brussels airport and metro station reigniting global concerns about terrorism.
VRX: 31.09 (-2.34), DAL: 47.84 (-1.07), PFE: 30.08 (-0.11), DB: 17.54 (-0.46), LL: 13.15 (+0.61), PCLN: 1,301.19 (-4.92), CELG: 100.54 (+0.62), UAL: 57.84 (-1.90), LUV: 44.06 (-0.37), GILD: 91.32 (+1.24), EXPE: 107.69 (-1.30), AAL: 40.50 (-1.42), AAPL: 105.67 (-0.46), IHG: 39.52 (+0.12)
Valeant Bids CEO Farewell, Embraces Ackman, and Shareholders Love It
at The Street - Tue Mar 22, 1:40PM CDT
Updated to reflect management pressure on boardmember Howard Shiller to step down, as the troubled drugmaker adds Bill Ackman to its board and CEO Michael Pearson steps down.
VRX: 31.09 (-2.34)
Options Play: Sell Valeant Puts
at The Street - Tue Mar 22, 1:02PM CDT
VRX put premiums are high, so use them to your advantage.
VRX: 31.09 (-2.34)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Valeant Pharmaceuticals International, Inc. -- VRX
Business Wire - Tue Mar 22, 12:48PM CDT
Levi & Korsinsky, LLP announces that it has commenced an investigation of Valeant Pharmaceuticals International, Inc. ("Valeant Pharmaceuticals" or the "Company"
(NYSE:VRX) concerning possible violations of federal securities laws by certain officers and directors. VRX: 31.09 (-2.34), VRX.TO: 41.21 (-2.95)
Trending Tickers: NKE, PBR, VRX, DKS
at The Street - Tue Mar 22, 12:10PM CDT
U.S. markets have been able to shake off investor fears following a terrorist attack in Belgium.
PBR: 5.40 (+0.04), VRX: 31.09 (-2.34), NKE: 61.65 (-0.79), DKS: 46.71 (+0.08), MFRM: 39.30 (+0.09)
Jim Cramer -- Bernie Sanders Dropout Could Rally Biotech Stocks
at The Street - Tue Mar 22, 11:57AM CDT
If Hillary Clinton can knock Bernie Sanders from the Democratic presidential race, it could spur a rally in the biotech sector, says Jim Cramer.
VRX: 31.09 (-2.34), AMGN: 149.24 (+0.48), IBB: 255.48 (+1.22)
(0)
(0)